The average one-year price target for Revelation Biosciences (NasdaqCM:REVB) has been revised to $21.68 / share. This is a decrease of 65.82% from the prior estimate of $63.42 dated August 30, 2025.

The price target is an average of many targets provided by analysts. The latest targets range from a low of $20.20 to a high of $23.62 / share. The average price target represents an increase of 1,028.91% from the latest reported closing price of $1.92 / share.

What is the Fund Sentiment?

There are 1 funds or institutions reporting positions in Revelation Biosciences. This is an decrease of 7 owner(s) or 87.50% in the last quarter. Total shares owned by institutions decreased in the last three months by 74.27% to 1K shares.

What are Other Shareholders Doing?

SBI Securities Co. holds 1K shares representing 0.08% ownership of the company. No change in the last quarter.